🧠Meningioma - Feb 2026
• Tumor microenvironment challenges traditional meningioma classification
• CDKN2A/B deletions linked to worse prognosis
• KMT2C loss drives NF2-wildtype progression via ferroptosis sensitivity
• Seizure-causing meningiomas show distinct molecular features
• Progestogen use raises intracranial meningioma risk
• Y chromosome loss tied to higher tumor grades in males
